T3	Treatment 0 6;107 117	Niacin high doses
T5	Effect 16 52	reversible toxic cystoid maculopathy
T7	Drug 0 6	Niacin
T4	Subject 68 99	approximately 0.67% of patients
T8	Population 82 87	0.67%
T9	Dosage 107 117	high doses
T6	Adverse_event 7 13	causes
E1	Adverse_event:T6